Company Directory / research

PrivateFor profitresearchHang Zhou Shi, China
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.
Size
11-50 people: larger than 33% of companies with a size listed
Age
8 years old.
Reach
Website ranked #11,521,910 in the world for traffic, about 156 visits a month.
Biotechnology
Funding, as listed
$1.7B currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Worg Pharmaceuticals, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Worg Pharmaceuticals may be growing as it has recently acquired Diater from Nazca Capital, which indicates an expansion of its business operations. This acquisition is a strategic move that could potentially enhance the company's product portfolio and market presence in the biopharmaceutical industry. The involvement of multiple financial and market sources in the consultation process suggests that this move is significant and could have a positive impact on the company's growth trajectory.
Summaries written by the source dataset, not by us, and not checked.
research in China.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 38,667 companies in China and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.